Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15959737 | 1.00 | MAPT (0.44) | MAPTKDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL17789544 | 0.94 | PDK2 (0.47) | MAPTKDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL17929492 | 0.83 | PDK2 (0.48) | MAPTKDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL2021618 | 0.82 | MAPT (0.59) | MAPTKDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL1615040 | 0.82 | MAPT (0.59) | MAPTKDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL17536913 | 0.82 | MAPT (0.59) | MAPTKDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL3456619 | 0.82 | MAPT (0.59) | MAPTKDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL12873471 | 0.77 | PDK2 (0.43) | MAPTKDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL15960805 | 0.77 | HTR1D (0.38) | CA1CA2 | |
| SCHEMBL17071053 | 0.77 | PDK2 (0.35) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-14 | — | — | US | disclosed |
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-14 | — | — | US | disclosed |
| US-9166177-B2 | Ditriphenylene derivative and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2015-10-20 | — | — | US | disclosed |
| US-9166177-B2 | Ditriphenylene derivative and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2015-10-20 | — | — | US | disclosed |
| US-20140231754-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Yen, Feng-wen (TW) | 2014-08-21 | — | — | US | disclosed |
| US-20140231754-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Yen, Feng-wen (TW) | 2014-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | NR2E1, NR0B1, NR2E3 | MAPT 4195/4885KDM4E 1506/4885ALDH1A1 3346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.